Mo, Jianshan
Deng, Lin
Peng, Keren
Ouyang, Shumin
Ding, Wen
Lou, Linlin
Lin, Ziyou
Zhu, Jianzheng
Li, Jingwei
Zhang, Qiyi
Wang, Pengyan
Wen, Yuanzhen
Chen, Xiaobing
Yue, Peibin
Lu, Jin-Jian
Zhu, Kai
Zheng, Yongjiang
Wang, Yuanxiang
Zhang, Xiaolei
Funding for this research was provided by:
National Natural Science Foundation of China (81973359, 82273958, 21977128, 81973359, 82273958, 21977128)
Natural Science Foundation of Guangdong Province (2022A1515012204, 2022A1515012204)
Guangzhou Science, Technology and Innovation Commission (202002030408, 202103000097, 202206080007, 202002030408, 202103000097, 202206080007)
Article History
Received: 16 December 2022
Accepted: 10 February 2023
First Online: 27 February 2023
Declarations
:
: All in vivo experiments were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (SYSU-IACUC-2022–000185) and followed the Guide for the Care and Use of Laboratory Animals. The primary leukemia patient samples were obtained under protocols reviewed and approved by the Human Ethics Committee of the Third Affiliated Hospital of Sun Yat-Sen University.
: Consent to publish has been obtained from all authors.
: All the authors declare no competing interest.